CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
Hae Jin Kim, In Kyung Jeong, Kyu Yeon Hur, Soo-Kyung Kim, Jung Hyun Noh, Sung Wan Chun, Eun Seok Kang, Eun-Jung Rhee, Sung Hee Choi
Diabetes Metab J. 2022;46(5):689-700.   Published online March 17, 2022
DOI: https://doi.org/10.4093/dmj.2021.0183

Excel Download

Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
Diabetes & Metabolism Journal. 2022;46(5):689-700   Crossref logo
Link1 Link2 Link3

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study
Diabetes, Obesity and Metabolism. 2011;13(11):1028-1035   Crossref logo
Link1 Link2

Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
Diabetes & Metabolism Journal. 2020;44(1):67   Crossref logo
Link1 Link2 Link3

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
Journal of Diabetes Investigation. 2012;3(6):517-525   Crossref logo
Link1 Link2

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
Diabetes, Obesity and Metabolism. 2012;14(10):927-936   Crossref logo
Link1 Link2

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension
Diabetes, Obesity and Metabolism. 2013;16(5):418-425   Crossref logo
Link1 Link2

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;Volume 14:1243-1252   Crossref logo
Link1 Link2

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study
Diabetes, Obesity and Metabolism. 2015;17(12):1198-1201   Crossref logo
Link1 Link2

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014;277   Crossref logo
Link1

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
Diabetes, Obesity and Metabolism. 2009;11(2):167-176   Crossref logo
Link1 Link2